# Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis

> **NCT05720715** · PHASE4 · COMPLETED · sponsor: **Farwaniya Hospital** · enrollment: 30 (actual)

## Conditions studied

- Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis

## Interventions

- **DRUG:** cyclosporine A 0.05% eye drops

## Key facts

- **NCT ID:** NCT05720715
- **Lead sponsor:** Farwaniya Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720715, "Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05720715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*